The Dilemma of Two Innovative Therapies for Spinal Muscular Atrophy
N Engl J Med
.
2017 Nov 2;377(18):1786-1787.
doi: 10.1056/NEJMe1712106.
Author
Ans T van der Ploeg
1
Affiliation
1
From the Center for Lysosomal and Metabolic Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands.
PMID:
29091554
DOI:
10.1056/NEJMe1712106
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Muscular Atrophy, Spinal*
Therapies, Investigational*